Table 3 Crude and age-appropriate vaccination coverage in Nepal (n = 460)
Vaccines | Crude coverage | Age-appropriate coverage | Early vaccination | Delayed vaccination |
|---|---|---|---|---|
Proportion (95% CI) | Proportion (95% CI) | Proportion, 95% CI | Proportion, 95% CI | |
BCG | 97.77 (95.85–98.75) | 54.58 (49.33–59.73) | – | 45.41 (40.26–50.67) |
OPV1 | 96.19 (94.00–97.60) | 73.13 (68.31–77.46) | 5.03 (3.20–7.84) | 21.83 (17.86–26.39) |
OPV2 | 95.56 (93.23–97.10) | 60.13 (54.97–65.07) | 1.82 (0.85–3.86) | 38.05 (33.17–43.18) |
OPV3 | 94.38 (91.86–96.16) | 41.74 (36.72–46.93) | 0.36 (0.06–2.00) | 57.91 (52.71–62.94) |
Penta1 | 97.69 (95.83–98.73) | 73.94 (69.24–78.14) | 4.70 (2.97–7.38) | 21.35 (17.49–25.80) |
Penta2 | 97.21 (95.22–98.38) | 60.61 (55.56–65.44) | 1.56 (0.69–3.46) | 37.83 (33.05–42.86) |
Penta3 | 91.49 (88.55–93.73) | 41.48 (36.54–46.59) | – | 58.38 (53.26–63.31) |
MMR1 | 96.15 (93.94–97.57) | 53.83 (48.53–59.04) | 11.00 (8.10–14.77) | 35.17 (30.30–40.38) |